Skip to main content
. 2017 Feb 13;8:16. doi: 10.3389/fpsyt.2017.00016

Figure 2.

Figure 2

Comparison of the KYNA/QUIN ratio at baseline (KYNA/QUIN V0) between remitters (n = 3) and non-remitters (n = 11) from the placebo group.